GlassScriptPhysician profile
Albert J Kim
NPI 1730475732
$4,748.97
in general payments reported to CMS, 2019-2025
21 companies · $60.41 in 2025
The $60.41 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,048 · 2020: $2,736 · 2021: $93.46 · 2022: $15.77 · 2023: $427 · 2024: $369 · 2025: $60.41.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $856.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $856.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $2,877.22 | 2019-2020 | |
| Linvatec Corporation | $288.57 | 2024 | Biobrace 23mm |
| Depuy Synthes Sales INC. | $219.67 | 2020-2025 | |
| Kci USA, INC. | $213.44 | 2019-2023 | Activ.A.C., V.A.C. Veraflo, Promogran Prisma |
| Acera Surgical, INC. | $158.17 | 2023 | Restrata Wound Matrix |
| Amniox Medical, INC. | $153.87 | 2020 | |
| Osiris Therapeutics INC. | $124.71 | 2019 | |
| Organogenesis INC. | $104.76 | 2020 | |
| Cardiovascular Systems INC. | $95.65 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $82.20 | 2023 | |
| Stryker Corporation | $70.63 | 2021 | |
| Smith+Nephew, INC. | $65.43 | 2019-2021 | |
| Horizon Therapeutics Plc | $56.95 | 2023 | Krystexxa |
| Bioventus LLC | $55.82 | 2024-2025 | Exogen Ultrasound Bone Healing System |
| Tactile Systems Technology INC | $51.96 | 2022-2024 | Entre Plus, Flexitouch Plus |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $36.99 | 2019-2020 | |
| Nevro Corp. | $26.13 | 2024 | Senza |
| Medtronic Vascular, INC. | $25.59 | 2019 | |
| Reprise Biomedical, INC. | $18.82 | 2024 | Miro3d |
| Sandoz INC. | $13.03 | 2019 | |
| Bard Peripheral Vascular, INC. | $9.36 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Albert Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.